Comparison of Adverse Clinical Outcomes in Children Hospitalized for Myocarditis with and Without COVID-19

Laxmi V Ghimire; Fu-Sheng Chou; Othman A Aljohani; Anita J Moon-Grady

doi:10.1016/j.jpeds.2023.113561

Comparison of Adverse Clinical Outcomes in Children Hospitalized for Myocarditis with and Without COVID-19

J Pediatr. 2023 Oct:261:113561. doi: 10.1016/j.jpeds.2023.113561. Epub 2023 Jun 14.

Authors

Laxmi V Ghimire¹, Fu-Sheng Chou², Othman A Aljohani¹, Anita J Moon-Grady³

Affiliations

¹ Division of Pediatric Cardiology, Department of Pediatrics, University of California, San Francisco, CA.
² Department of Neonatal-Perinatal Medicine, Kaiser Permanente Riverside Medical Center, CA.
³ Division of Pediatric Cardiology, Department of Pediatrics, University of California, San Francisco, CA. Electronic address: Anita.moongrady@ucsf.edu.

Abstract

We used a nationally representative database of the US, which included 1995 myocarditis cases, among whom 620 children had COVID-19. While the risk of in-hospital mortality was not higher, illness severity and length of hospital stay were higher in patients with myocarditis and COVID-19 than those without COVID-19.

Publication types

Case Reports

MeSH terms

COVID-19*
Child
Humans
Length of Stay
Myocarditis* / therapy